Published in Am J Pathol on April 01, 2007
Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Arthritis Rheum (2010) 1.63
Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 1.40
Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy. J Heart Lung Transplant (2010) 1.35
Role of anti-vimentin antibodies in allograft rejection. Hum Immunol (2013) 1.09
HLA and MICA: targets of antibody-mediated rejection in heart transplantation. Transplantation (2011) 0.99
Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant (2009) 0.97
Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study. Arthritis Res Ther (2012) 0.94
Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis. Arthritis Rheumatol (2014) 0.91
Non-MHC antigenic targets of the humoral immune response in transplantation. Curr Opin Immunol (2010) 0.91
Antibody-mediated rejection: emergence of animal models to answer clinical questions. Am J Transplant (2010) 0.87
Immune response to extracellular matrix collagen in chronic hepatitis C-induced liver fibrosis. Liver Transpl (2011) 0.86
Anti-CCP antibody in patients with established rheumatoid arthritis: Does it predict adverse cardiovascular profile? J Cardiovasc Dis Res (2013) 0.84
Vimentin is an endogenous ligand for the pattern recognition receptor Dectin-1. Cardiovasc Res (2013) 0.84
Antibodies in transplantation: the effects of HLA and non-HLA antibody binding and mechanisms of injury. Methods Mol Biol (2013) 0.84
Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis. Front Immunol (2015) 0.82
Changes in regulation of human monocyte proteins in response to IgG from patients with antiphospholipid syndrome. Blood (2014) 0.79
Effector mechanisms of rejection. Cold Spring Harb Perspect Med (2013) 0.79
Vimentin is a target of PKCβ phosphorylation in MCP-1-activated primary human monocytes. Inflamm Res (2013) 0.79
Altered Traffic of Cardiolipin during Apoptosis: Exposure on the Cell Surface as a Trigger for "Antiphospholipid Antibodies". J Immunol Res (2015) 0.77
Impact of donor-specific antibodies on the outcomes of kidney graft: Pathophysiology, clinical, therapy. World J Transplant (2014) 0.77
Auto-antibodies to β-F1-ATPase and vimentin in malignant mesothelioma. PLoS One (2011) 0.76
The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis. Semin Nephrol (2015) 0.76
The Emerging Importance of Non-HLA Autoantibodies in Kidney Transplant Complications. J Am Soc Nephrol (2016) 0.75
Overview of pathophysiology and treatment of human lupus nephritis. Curr Opin Rheumatol (2016) 0.75
Generation of Antigen Microarrays to Screen for Autoantibodies in Heart Failure and Heart Transplantation. PLoS One (2016) 0.75
Th17 responses to Col V, kα-1-tubulin and vimentin are present early in human development and persist lifelong. Am J Transplant (2016) 0.75
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature (1998) 9.77
Regulatory T cells in autoimmmunity*. Annu Rev Immunol (2000) 9.36
Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med (1994) 8.21
Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation (1973) 6.01
Vimentin is secreted by activated macrophages. Nat Cell Biol (2003) 2.63
Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin. Arthritis Res Ther (2004) 2.58
Chronic renal allograft dysfunction. J Am Soc Nephrol (2005) 2.23
Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J Exp Med (1995) 1.86
Assessment of the contribution that direct allorecognition makes to the progression of chronic cardiac transplant rejection in humans. Circulation (1998) 1.79
Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J Exp Med (1998) 1.70
Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol (2002) 1.68
Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J Immunol (1999) 1.66
Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation (2001) 1.52
Peripheral T cell tolerance. Annu Rev Immunol (1992) 1.47
Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med (1992) 1.46
Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol (1994) 1.45
Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy. J Immunol (2001) 1.43
Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis. J Leukoc Biol (2005) 1.33
De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol (1999) 1.29
Apoptosis and autoimmunity. Curr Opin Immunol (2005) 1.25
Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Transplantation (2001) 1.24
Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface. J Biol Chem (2001) 1.21
Oral tolerance induction by type V collagen downregulates lung allograft rejection. Am J Respir Cell Mol Biol (2001) 1.19
Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation (2002) 1.17
Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest (1996) 1.16
Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transplant (2004) 1.14
The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report--2004. J Heart Lung Transplant (2004) 1.14
Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Circulation (2000) 1.14
Cardiac allograft vasculopathy: a review. Can J Surg (2005) 1.11
Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice. Transplantation (1997) 1.10
The male minor transplantation antigen preferentially activates recipient CD4+ T cells through the indirect presentation pathway in vivo. J Immunol (2003) 1.09
Beyond C4d: other complement-related diagnostic approaches to antibody-mediated rejection. Am J Transplant (2004) 1.06
Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2. Blood (2003) 1.04
Revisiting tolerance induced by autoantigen in incomplete Freund's adjuvant. J Immunol (2000) 1.04
Vimentin antibodies: a non-HLA antibody as a potential risk factor in renal transplantation. Transplant Proc (2005) 1.04
Humoral immunity to vimentin is associated with cardiac allograft injury in nonhuman primates. Am J Transplant (2005) 1.04
Cardiac myosin autoantibodies and acute rejection after heart transplantation in patients with dilated cardiomyopathy. Transplantation (2000) 1.02
Autoimmunity versus tolerance: can dying cells tip the balance? Clin Immunol (2006) 1.00
Pre- and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome. J Heart Lung Transplant (2004) 1.00
Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants. J Immunol (2002) 0.99
Conditional immortalization of growth factor-responsive cardiac endothelial cells from H-2K(b)-tsA58 mice. Am J Physiol Cell Physiol (2002) 0.96
Screening of a HUVEC cDNA library with transplant-associated coronary artery disease sera identifies RPL7 as a candidate autoantigen associated with this disease. Clin Exp Immunol (2001) 0.94
Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. Transplantation (2004) 0.94
Anti-intercellular adhesion molecule-1 antibodies in sera of heart transplant recipients: a role in endothelial cell activation. Transplantation (2005) 0.93
Much ado about minor histocompatibility antigens. Immunol Today (1998) 0.92
Characterization of endothelial antigens associated with transplant-associated coronary artery disease. J Heart Lung Transplant (1996) 0.91
Identification of a caspase-9 substrate and detection of its cleavage in programmed cell death during mouse development. J Biol Chem (2001) 0.91
Shifting T-cell activation thresholds in autoimmunity and determinant spreading. Immunol Rev (1998) 0.91
Progression of alloresponse and tissue-specific immunity during graft coronary artery disease. Am J Transplant (2005) 0.90
Direct and indirect pathways of alloantigen recognition: relevance to acute and chronic allograft rejection. Nephrol Dial Transplant (1997) 0.88
Intragraft activation of genes encoding cytotoxic T lymphocyte effector molecules precedes the histological evidence of rejection in human cardiac transplantation. Transplantation (2001) 0.88
Mechanisms of allo-recognition. Recognition by in vivo-primed T cells of specific major histocompatibility complex polymorphisms presented as peptides by responder antigen-presenting cells. Transplantation (1994) 0.87
Development of autoimmunity after skin graft rejection via an indirect alloresponse. Transplantation (2002) 0.87
Demonstration by western blotting of antiheart antibodies before and after cardiac transplantation. Transplantation (1991) 0.86
Induction of T cell responses to a self-antigen following allotransplantation. Transplantation (1996) 0.84
Complement as a mediator of vascular inflammation and activation in allografts. J Heart Lung Transplant (2000) 0.83
The autoimmune response to vimentin after renal transplantation in nonhuman primates is immunosuppression dependent. Transplantation (2005) 0.82
Anti-skeletal muscle glycolipid antibodies in human heart transplantation as markers of acute rejection. Correlation with endomyocardial biopsy. Transplantation (1996) 0.81
Correlation of Fas and Fas ligand expression with rejection status of transplanted heart in human. Transplantation (2001) 0.77
Complement causes allograft injury by cell activation rather than lysis. Transplantation (1999) 0.76
Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection. Sci Transl Med (2010) 5.85
Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res (2002) 2.73
Endothelium-dependent regulation of the mechanical properties of aortic valve cusps. J Am Coll Cardiol (2009) 1.85
Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valves. Tissue Eng (2006) 1.57
Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue. J Virol (2011) 1.56
Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts. Transplantation (2010) 1.50
Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc Res (2006) 1.47
Using the ISBAR handover tool in junior medical officer handover: a study in an Australian tertiary hospital. Postgrad Med J (2011) 1.45
Prevention of vaginal SHIV transmission in macaques by a coitally-dependent Truvada regimen. PLoS One (2012) 1.42
Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 1.40
Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitors. J Virol (2011) 1.38
Localization and pattern of expression of extracellular matrix components in human heart valves. J Heart Valve Dis (2005) 1.36
Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy. Cardiovasc Res (2008) 1.28
Revealing new mouse epicardial cell markers through transcriptomics. PLoS One (2010) 1.24
Cardiac fibrosis in mice expressing an inducible myocardial-specific Cre driver. Dis Model Mech (2013) 1.15
Developing sensors for real-time measurement of high Ca2+ concentrations. Biochemistry (2007) 1.14
Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques. Antimicrob Agents Chemother (2012) 1.11
Magnetic resonance imaging of ferumoxide-labeled mesenchymal stem cells seeded on collagen scaffolds-relevance to tissue engineering. Tissue Eng (2006) 1.10
Expression of follistatin-related genes is altered in heart failure. Endocrinology (2008) 1.07
Side-specific endothelial-dependent regulation of aortic valve calcification: interplay of hemodynamics and nitric oxide signaling. Am J Pathol (2013) 1.07
On-line coupling of anion exchange and ion-pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitors. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.06
Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases. Eur J Endocrinol (2010) 1.04
Humoral immunity to vimentin is associated with cardiac allograft injury in nonhuman primates. Am J Transplant (2005) 1.04
Role of anti-vimentin antibodies in renal transplantation. Transplantation (2014) 1.00
HLA and MICA: targets of antibody-mediated rejection in heart transplantation. Transplantation (2011) 0.99
Use of proteomics to discover novel markers of cardiac allograft rejection. J Proteome Res (2004) 0.99
A naturally occurring calcineurin variant inhibits FoxO activity and enhances skeletal muscle regeneration. J Cell Biol (2007) 0.99
A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping. PLoS One (2010) 0.98
A novel role of the sympatho-adrenergic system in regulating valve calcification. Circulation (2007) 0.97
Characterization of structural and signaling molecules by human valve interstitial cells and comparison to human mesenchymal stem cells. J Heart Valve Dis (2007) 0.95
Genetic or pharmaceutical blockade of phosphoinositide 3-kinase p110δ prevents chronic rejection of heart allografts. PLoS One (2012) 0.94
Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. Transplantation (2004) 0.94
Acrogeric Ehlers-Danlos syndrome type IV: report of a new patient with additional findings. Eur J Dermatol (2002) 0.93
Anti-intercellular adhesion molecule-1 antibodies in sera of heart transplant recipients: a role in endothelial cell activation. Transplantation (2005) 0.93
A novel strategy for myocardial protection by combined antibody therapy inhibiting both P-selectin and intercellular adhesion molecule-1 via retrograde intracoronary route. Circulation (2006) 0.90
Extracellular matrix production by adipose-derived stem cells: implications for heart valve tissue engineering. Biomaterials (2010) 0.89
IFN-gamma reverses the stop signal allowing migration of antigen-specific T cells into inflammatory sites. J Immunol (2003) 0.89
Evaluation of nanoparticle uptake in tumors in real time using intravital imaging. J Vis Exp (2011) 0.86
Characterization of porcine aortic valvular interstitial cell 'calcified' nodules. PLoS One (2012) 0.85
Indirect allorecognition can play an important role in the development of transplant arteriosclerosis. Transplantation (2002) 0.84
TLR5 risk-associated haplotype for canine inflammatory bowel disease confers hyper-responsiveness to flagellin. PLoS One (2012) 0.84
Enhanced efficiency of superoxide dismutase-induced cardioprotection by retrograde intracoronary administration. Cardiovasc Res (2005) 0.83
Sequential expression of three known protective genes in cardiac biopsies after transplantation. Transplantation (2005) 0.83
Calcineurin splicing variant calcineurin Aβ1 improves cardiac function after myocardial infarction without inducing hypertrophy. Circulation (2011) 0.83
Protective effect of phosphorylated Hsp27 in coronary arteries through actin stabilization. J Mol Cell Cardiol (2010) 0.82
UC781 microbicide gel retains anti-HIV activity in cervicovaginal lavage fluids collected following twice-daily vaginal application. Antimicrob Agents Chemother (2012) 0.82
Expression of human ecto-5'-nucleotidase in pig endothelium increases adenosine production and protects from NK cell-mediated lysis. Am J Transplant (2005) 0.82
An evaluation of the Ross operation in adults. J Heart Valve Dis (2006) 0.81
Influence of ivabradine on reverse remodelling during mechanical unloading. Cardiovasc Res (2012) 0.81
A reevaluation of the role of IgM Non-HLA antibodies in cardiac transplantation. Transplantation (2009) 0.81
Ablation of SGK1 impairs endothelial cell migration and tube formation leading to decreased neo-angiogenesis following myocardial infarction. PLoS One (2013) 0.81
Predicting impending rupture of the ascending aorta with bicuspid aortic valve: spatiotemporal flow and wall shear stress. JACC Cardiovasc Imaging (2013) 0.80
Interaction between bone morphogenetic proteins and endothelin-1 in human pulmonary artery smooth muscle. Vascul Pharmacol (2009) 0.80
Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody. Transplantation (2012) 0.80
Confusing genes: a patient with MEN2A and Cushing's disease. Clin Endocrinol (Oxf) (2013) 0.80
Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts. Transplantation (2002) 0.79
Expression of endothelial intercellular adhesion molecule-1 is determined by genotype: effects on efficiency of leukocyte adhesion to human endothelial cells. Hum Immunol (2008) 0.79
Preparation of human heart for laser microdissection and proteomics. Proteomics (2004) 0.78
A role for indirect allorecognition in lung transplant recipients with obliterative bronchiolitis. Am J Transplant (2003) 0.78
The indirect alloimmune response causes microvascular endothelial dysfunction-a possible role for alloantibody. Transplantation (2010) 0.78
Expression and localization of C-type natriuretic peptide in human vascular smooth muscle cells. Vascul Pharmacol (2006) 0.78
Localisation and function of nerves in the aortic root. J Mol Cell Cardiol (2008) 0.78
Interferon-gamma and intimal hyperplasia. Circ Res (2007) 0.78
Heat shock protein-27 delays acute rejection after cardiac transplantation: an experimental model. Transplantation (2014) 0.77
Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5'-nucleotidase (CD73) in pig aortic valves. Nucleosides Nucleotides Nucleic Acids (2014) 0.77
Effect of phosphorylated hsp27 on proliferation of human endothelial and smooth muscle cells. Proteomics (2009) 0.77
Effect of cognate human CD4+ T cell and endothelial cell interactions upon chemokine production. Transplantation (2004) 0.77
Antioxidant properties of the internal thoracic artery and the radial artery. Heart Lung Circ (2007) 0.77
POPDC1S201F causes muscular dystrophy and arrhythmia by affecting protein trafficking. J Clin Invest (2015) 0.77
CD8(+) T cells induce graft vascular occlusion in a CD40 knockout donor/recipient combination. J Heart Lung Transplant (2003) 0.76
Side-specific mechanical properties of valve endothelial cells. Am J Physiol Heart Circ Physiol (2014) 0.76
Management of an ABO-incompatible lung transplant. Am J Transplant (2004) 0.76
Biomarkers of rejection: are we any closer to the Philosopher's Stone? Transplantation (2009) 0.75
Increased cardiogenesis in P19-GFP teratocarcinoma cells expressing the propeptide IGF-1Ea. Biochem Biophys Res Commun (2011) 0.75
Letter by Rose and Dunn regarding article, "Expression of heat shock protein 27 in human atherosclerotic plaques and increased plasma level of heat shock protein 27 in patients with acute coronary syndrome". Circulation (2007) 0.75
Intramyocardial cell delivery: observations in murine hearts. J Vis Exp (2014) 0.75
High diversity of non-human leukocyte antigens in transplant-associated coronary artery disease. Transplantation (2003) 0.75
Levels of intracellular phosphorylated tenofovir and emtricitabine correlate with natural substrate concentrations in peripheral blood mononuclear cells of persons prescribed daily oral TruvadaTM for HIV pre-exposure prophylaxis. J Acquir Immune Defic Syndr (2017) 0.75
British transplant research endangered by the Human Tissue Act. J Med Ethics (2011) 0.75
Urine tenofovir and emtricitabine concentrations provide biomarker for exposure to HIV preexposure prophylaxis. AIDS (2017) 0.75
Antibody alone is not a stimulator of exocytosis of Weibel-Palade bodies from human endothelial cells. Transplantation (2012) 0.75
Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patients. Transplantation (2007) 0.75
Solid phase assay measuring C4d deposition to determine complement fixation by HLA-specific antibodies. Methods Mol Biol (2013) 0.75
Lack of in vitro-in vivo correlation for a UC781-releasing vaginal ring in macaques. Drug Deliv Transl Res (2015) 0.75